Clinical trials
Aspiration clinical trials
Below are recruiting aspiration clinical trials, each written for real people, not researchers. We’re tracking 265 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07077343Recruiting
AI-guided blood clot removal vs. standard care for brain bleeding
This study compares a new AI-guided procedure to remove blood clots from the brain with standard medical treatment. It may help people who had a stroke from high blood pressure and have a medium-sized bleed in the upper part of the brain.
Beijing, Beijing MunicipalityAges 18–80 - NCT06988280Recruiting
Draining pelvic cysts through the vagina with ultrasound
This trial drains fluid-filled cysts in the pelvis (like ovarian cysts or abscesses) through the vagina using an ultrasound to guide the needle. It aims to relieve pain and symptoms, especially when surgery or cure isn't an option.
Leuven, Vlaams-BrabantAges 18 years+ - NCT06984991Recruiting
Why some thyroid biopsy samples are hard to evaluate quickly
This trial looks at what makes it harder to quickly tell if a thyroid nodule sample is good enough for diagnosis during your biopsy. It may help doctors improve the procedure for people with suspicious nodules.
Asyut, Asyut GovernorateAges 18 years+ - NCT06893302Recruiting
Bone marrow injection during knee scope for cartilage or meniscus
This trial tests if adding a bone marrow injection to standard knee arthroscopy helps your knee heal better. It is for people with a torn meniscus or damaged cartilage who have healthy knee joints without arthritis.
New York, New YorkAges 18–64 - NCT06747117Recruiting
Removing blood clots in leg arteries with the Indigo system
This study tests a device that vacuums out blood clots from blocked leg arteries, potentially restoring blood flow without open surgery.
Scottsdale, ArizonaAges 18 years+ - NCT02647177Recruiting
Blood and cyst fluid study for pancreatic cyst conditions
This study looks for “biomarkers,” or measurable lab signals, in blood and (when available) cyst fluid to understand pancreatic cyst problems and related conditions. It may help doctors better predict what these conditions are and how to manage them.
Houston, TexasAges 18–100 - NCT06654453Recruiting
Blood clot removal during heart attack treatment
This trial tests whether removing the blood clot from the heart artery during a stent procedure can improve outcomes for people having a heart attack. If you fit the criteria, you may be randomly assigned to receive this extra clot-removal step or the standard stent procedure alone.
Changsha, HunanAges Any age - NCT06123481Recruiting
Bone marrow treatment for early hip bone loss
This trial tests whether injecting your own bone marrow into the hip can help heal early-stage osteonecrosis (bone death) before the bone collapses. It is for people who have not had prior hip surgery and do not have certain conditions like sickle cell disease.
Los Angeles, CaliforniaAges 18–90 - NCT06047093Recruiting
Study of Hepatitis B Virus in the Liver
This study collects a small sample of liver cells to understand how hepatitis B virus behaves in the liver and how the immune system responds. This could help improve future treatments for chronic hepatitis B.
LyonAges 18 years+ - NCT06029491Recruiting
Studying a new suction device for stroke treatment
This trial tests a new device that removes blood clots in the brain using suction. It is for people having a large-vessel ischemic stroke who can be treated within 8 hours of symptoms starting.
Torrance, CaliforniaAges 18–80 - NCT05789940Recruiting
Hysteroscopy vs suction for retained pregnancy tissue
This study compares two outpatient procedures—hysteroscopy and suction—to remove retained pregnancy tissue after a miscarriage in the first 3 months. The goal is to find which method works best and is safest for people who choose surgical treatment.
BordeauxAges 18–42 - NCT05711849RecruitingPhase 2
Stem cell treatment for long-lasting chest pain not helped by meds
This Phase 2 trial tests whether stem cells placed into the heart artery can safely reduce symptoms in people with “refractory” angina (chest pain) despite maximum heart-healthy medication. You may qualify if your chest pain is limiting your activity and other heart procedures (stents/bypass) aren’t possible or are too risky.
London, EnglandAges 18 years+ - NCT05674643Recruiting
Gastric testing during children’s surgery
This trial studies how the stomach is working in children around the time of surgery. It may help improve how doctors assess and manage stomach function to make surgery safer and more comfortable.
Boston, MassachusettsAges 2–18 - NCT05455359RecruitingPhase 4
Tube-fed children at high risk for aspiration pneumonia
This Phase 4 study looks at gastrointestinal movement (dysmotility) and how it may increase the risk of aspiration pneumonia in children who eat through a tube and have swallowing safety problems. It may help doctors better prevent lung infections in children who cough/choke and need suction often.
Boston, MassachusettsAges 5–21 - NCT04990128RecruitingPhase 3
Bone marrow fluid injection versus steroid shots for hip arthritis
This trial compares a “bone marrow aspirate concentrate” injection with a corticosteroid (steroid) injection to reduce pain from hip osteoarthritis. It aims to see which treatment works better over time for hip pain and function.
Weston, FloridaAges 18–75 - NCT04798261Recruiting
Long-term follow-up after clot removal for pulmonary embolism
This study tracks how patients do long-term after having a clot in the lung treated with a device called the Indigo Aspiration System. It aims to better understand safety and outcomes over time.
Long Beach, CaliforniaAges 18 years+ - NCT04212494Recruiting
Aspirating clot during heart procedure for certain heart attacks
This trial studies whether removing (“aspirating”) a blood clot during an emergency heart procedure works better for people having a specific type of heart attack with a large clot burden. It may help improve blood flow after treatment, but it is only for patients who meet several timing and safety conditions.
Fuzhou, FujianAges 18 years+ - NCT07437963RecruitingPhase 1/Phase 2
Iberdomide plus chemoimmunotherapy for neuroblastoma that returned or did not respond
This trial tests adding a new drug called iberdomide to an existing chemoimmunotherapy regimen for children and young adults with neuroblastoma that has come back or not responded to treatment. The goal is to see if the combination is safe and more effective than current treatments.
Oakland, CaliforniaAges 1–30 - NCT07463807RecruitingPhase 1/Phase 2
Comparing two drug combinations for multiple myeloma that returned quickly
This study tests a new combination of two drugs, teclistamab and pomalidomide, against the usual treatment of three drugs for multiple myeloma that has come back shortly after a standard treatment. The goal is to see if the new combination works better or is safer.
Duarte, CaliforniaAges 18 years+ - NCT07133997RecruitingPhase 1
Combination therapy for relapsed CD19+ B-cell leukemia
This trial tests a new combination of three drugs for patients with relapsed or treatment-resistant CD19-positive B-cell acute lymphoblastic leukemia. It aims to see if adding the drugs venetoclax and asparaginase to blinatumomab can improve outcomes.
Duarte, CaliforniaAges 12–55 - NCT07437950RecruitingPhase 2
Comparing treatment lengths for venetoclax in older adults with newly diagnosed acute myeloid leukemia
This study tests whether a shorter or longer course of the drug venetoclax works better for older adults with a type of blood cancer called acute myeloid leukemia (AML) who are not healthy enough for intensive chemotherapy. The goal is to find the best treatment duration to control the cancer while reducing side effects.
Coeur d'Alene, IdahoAges 60 years+ - NCT07877025Recruiting
Follicle flushing compared with direct aspiration for egg retrieval
This study compares two ways of collecting eggs from the ovaries during a procedure done through the abdomen, rather than through the vagina. It aims to see if flushing the follicle (washing out the egg) works better than directly sucking it out, which could help women who cannot or prefer not to have the usual vaginal procedure.
Ankara, AnkaraAges 18–42 - NCT07731789RecruitingPhase 2
Antibody combo for newly diagnosed follicular lymphoma
This trial tests two antibody medications, tafasitamab and rituximab, as the first treatment for newly diagnosed follicular lymphoma. The goal is to see if this combination can effectively control the lymphoma and potentially reduce the need for more intensive therapies.
Seattle, WashingtonAges 18 years+ - NCT07557056RecruitingPhase 2
Oral combination treatment for untreated chronic lymphocytic leukemia
This clinical trial tests two oral medications, nemtabrutinib and venetoclax, given together to people with untreated CLL or SLL. The goal is to see if this combination effectively kills cancer cells and helps you stay in remission with manageable side effects.
Columbus, OhioAges 18 years+
Hear when a new Aspiration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for aspiration?
- Yes. Clin2 currently lists 265 recruiting aspiration studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a aspiration trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a aspiration trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.